Nanoform, a pioneering nanoparticle medicine-enabling company, has announced a groundbreaking collaboration with AstraZeneca Plc. Under this partnership, Nanoform has granted AstraZeneca a global license to access STARMAP®, a digital AI version of the CESS® technology. STARMAP® facilitates in-silico experiments that aid in the selection of molecules for nanoforming. This strategic move will empower AstraZeneca to ... Read more